1624. Real World Experience with Daptomycin (DAP) and Ceftaroline (CPT) Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia

BACKGROUND: Methicillin-resistant Staphylococcus aureus bacteremia is associated with significant mortality rates up to 30%. Guideline-recommended first-line therapy includes monotherapy with either vancomycin or DAP. Alternative regimens are recommended for persistent MRSA bacteremia of ≥ 7 days or...

Descripción completa

Detalles Bibliográficos
Autores principales: Zidaru, Andrei, Russo, Hannah Ryan, Phe, Kady
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778244/
http://dx.doi.org/10.1093/ofid/ofaa439.1804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778244/
http://dx.doi.org/10.1093/ofid/ofaa439.1804

Ejemplares similares